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Abstract 
As indicated by its name, Matrin3 was discovered as a component of the nuclear 
matrix, an insoluble fibrogranular network that structurally organizes the nucleus. 
Matrin3 possesses both DNA and RNA binding domains and, consistent with this, 
has been shown to function at a number of stages in the life-cycle of mRNAs. These 
numerous activities indicate that Matrin3, and indeed the nuclear matrix, do not just 
provide a structural framework for nuclear activities, but play direct functional roles in 
these activities. Here we review the structure, functions, and molecular interactions 
of Matrin3 and of Matrin3-related proteins, and the pathologies that can arise upon 
mutation of Matrin3. 
 
Introduction 
Matrin3 was first identified as a major component of the nuclear matrix1, 2, 
which connects the nuclear membrane and the lamin class of intermediate filaments 
to intra-nuclear structures (see Box 1). The nuclear matrix acts as a scaffold for 
attachment of chromatin, both active and inactive, binding to specific regions on the 
chromosomes termed scaffold/matrix attachment regions (S/MARs)3. The S/MARs 
have been associated with various functions including regulation of transcription4, 5, 
RNA processing6, insulation of genomic domains7 and facilitating DNA replication8. 
Thus, attachment of chromatin to the nuclear matrix not only spatially organizes the 
nucleus, but also contributes to numerous nuclear functions.  
 
 
Box 1. The nuclear matrix 
The nuclear matrix consists of a non-chromatin fibrogranular ribonucleoprotein network 
located within the nucleus but connecting with the internal surface of the nuclear membrane, 
interior to the nuclear lamina. Sometimes called the nuclear scaffold or skeleton, historically 
the nuclear matrix has been defined in two complementary ways. First, and most 
importantly, electron microscopy allowed direct visualization of an extensive non-chromatin 
branched fibrogranular ribonucleoprotein network that had not been evident in earlier 
analyses by light microscopy9. Biochemical approaches identified the matrix as a structure 
resistant to sequential extractions, including high concentrations of salt, non-ionic detergents 
and digestion with DNase. These treatments remove both soluble complexes such as the 
spliceosome as well as some insoluble complexes including chromatin. The general 
structure of the nuclear matrix is insensitive to DNase treatment, emphasizing the identity of 
the matrix as a separate entity from chromatin, albeit one that is proposed to organize 
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chromatin loops via interaction at S/MARs. Conversely, the matrix is sensitive to RNase 
digestion, indicating that ribonucleoprotein complexes are integral to the structure, and 
presumably functions, of the matrix10. One of the major challenges in understanding the 
nuclear matrix is defining the major protein constituents that underlie the observed 
filamentous structure; proteomic analyses indicate a highly complex composition11, including 
many RNA binding proteins. The matrix-association of proteins known to be active in various 
nuclear processes argues for the functional importance of the matrix. Nevertheless it should 
be noted that the concept of a nuclear matrix is not universally accepted12, 13.  
 
 
Matrin3 was identified by analysis of the protein complement of the 
biochemically defined nuclear matrix fraction1. To characterize the key players of the 
nuclear matrix, Berezney and colleagues used two-dimensional polyacrylamide gels 
to separate and identify the major protein components of the extracted nuclear 
matrix from rat liver cells1. Together with the lamins A, B and C, other abundant 
proteins were identified, including Matrins 3, 12, 13, D/E, F/G (Prostaglandin 
transporter SLC21A2), PSF/SFPQ (at the time named Matrin4) and nucleophosmin 
(also known as B-23), as well as several hnRNPs. Subsequently, many other 
proteins have been found to localize to this structure and have been identified using 
quantitative proteomic tools11. Taking a complementary approach Sugano and 
colleagues identified a 130kDa protein, initially named P130 after its gel migration 
size, which binds to AT-rich sequences found in highly repetitive matrix-associated 
DNA sequences, and upon protein sequence analysis revealed to be Matrin314, 15. 
Although a major component of the matrix that provides structure and 
organization to the nucleus, the majority of the 847 amino acids of Matrin3 comprise 
intrinsically disordered regions, with the exceptions of two zinc-finger domains and 
two tandem RNA binding domains16. The assumption that its matrix localization 
implies a passive structural role could not be further from the truth; Matrin3 has been 
associated with functions ranging from transcription regulation, pre-mRNA splicing, 
mRNA stability, DNA damage repair to cell proliferation (see below). The 
involvement of Matrin3 and other nuclear matrix proteins in these processes 
suggests that the nuclear matrix might have important roles not only in the spatial 
organization and compartmentalization, but also in the activity of the specialized 
machineries involved in these various nuclear functions.  
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Domain structure and function of Matrin3 
 Four distinguishable structured domains are present in Matrin3 (Fig. 1A), two 
DNA binding C2H2 zinc-finger domains (ZF) and two RNA binding domains of the 
RNA recognition motif type (RRM)16. In addition to these domains there are also a 
bipartite nuclear localization signal (NLS) and a nuclear export signal (NES)16, 17. 
Most of the remaining protein sequence is predicted to be disordered, and therefore 
might be dedicated to mediating protein-protein interactions, as motifs for protein 
interactions are commonly found in disordered regions18. One such motif is a PTBP1 
RRM interaction motif (PRI), a 7 amino acid motif that mediates interaction with the 
splicing regulator polypyrimidine tract binding protein (PTBP1) and possibly other 
proteins19. 
Along with Lamin B, Matrin3 is one of the few nuclear matrix proteins that do 
not bind to total genomic DNA from rat liver, when analysed for DNA binding by 
southwestern blot20. Nevertheless, subsequent studies have shown that Matrin3 can 
bind to at least some DNA sequences14-16. The two zinc-finger (ZF) domains belong 
to the U1-like zinc finger family although in contrast to the member that gives name 
to the family, U1C21, the ZF domains in Matrin3 mediate interaction with DNA16. The 
two ZF domains show some redundancy as deletion of both ZF1 and ZF2 is required 
to impair DNA binding, assayed by electrophoretic mobility shift assay (EMSA), and 
recruitment to chromatin in cells or in biochemically fractionated chromatin16. The ZF 
domains cannot compensate binding to RNA when the RRM domains are deleted16. 
The ZF domains are possibly associated with roles in chromosome positioning, 
transcription regulation and/or genic insulation as all these typically involve DNA 
binding proteins. Deletion of the ZF domains does not affect the general role of 
Matrin3 in alternative splicing regulation, but it remains possible that it interacts with 
DNA to regulate specific co-transcriptional RNA processing events19.  
The two RRM domains of Matrin3 are most similar to the RRM domains of 
PTBP1 and hnRNPL16, with 37% sequence identity to the first of the four RRM 
domains of PTBP1. The AUCUU motif was determined as the optimal RNA binding 
site for the tandem RRMs of Matrin3 by RNA-compete array-based selection as part 
of a study characterizing the binding sites for 207 RNA binding proteins22. Whether 
this motif reflects optimal binding to one or both RRMs currently remains unclear, 
since the 5-mer length of this motif is consistent with interaction of a single RRM 
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domain23. There is evidence that some RNA-dependent protein interactions require 
the second RRM but not the first, suggesting that RRM2 might play the dominant 
role in RNA binding24. The AUCUU motif is similar to the UUUCU motif bound by 
PTBP1, which directly interacts with Matrin3 and cooperates with it in alternative 
splicing regulation. The two tandem RRMs of Matrin3 bind to the regulated RNA 
targets and are required for its role in splicing regulation and RNA stabilization19, 24. 
RNA map constructed by mapping Matrin3 iCLIP tags onto the Matrin3 regulated 
splicing events suggests that in vivo RNA binding might involve initial binding to 
specific sites followed by oligomerization along the RNA25 (see below).  
Immunofluorescence microscopy found Matrin3 as a mainly nuclear protein in 
various mammalian cell lines, where it localizes throughout the nucleoplasm with the 
exception of the nucleolus26, 27. Nuclear matrix localization of proteins like SATB1, 
Runx and AML-1 is mediated through a nuclear matrix targeting sequence (NMTS) 
distinct from the NLS28, 29, but a functionally equivalent motif could not be identified in 
Matrin3. Although Matrin3 was originally discovered by its presence in nuclear matrix 
fractions, biochemical fractionation and western blotting show it is also present in 
soluble nucleoplasmic fractions16, 19, and to some extent also in cytoplasmic 
fractions, albeit at lower levels than in the nucleus16. The lack of an identified NMTS 
in Matrin3 means that it is not yet possible to determine which of its nuclear functions 
depend on its matrix localization. Shuttling between the nucleus and cytoplasm is 
mediated by the nuclear export signal (NES) located at the N-terminus, and the bi-
partite nuclear localization signal (NLS) located between the second RRM and the 
second ZF domain16, 17 (Fig.1A). Although no evidence for a cytoplasmic role has yet 
been described, the presence of a NES and some cytoplasmic localization suggest 
that such a role may exist. 
 
Molecular interactions of Matrin3 
Matrin3 can interact with multiple nuclear proteins, a high proportion of which 
are involved in RNA binding and/or processing (Table 1). Some of these are 
important for Matrin3 function, including the interactions with PTBP1, NONO (also 
known as p54nrb) and PSF (reviewed in30), but the function of other interactions 
remains unclear. The domains and motifs mediating most direct protein-protein 
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interactions remain unclear, with one exception being the PRI-mediated interaction 
with PTBP119. In fact, some of the reported interactions might be indirectly bridged 
by RNA, since they were identified by techniques that do not distinguish between 
direct and RNA-bridged interactions, including yeast two hybrid (Y2H) and 
immunoprecipitation (IP) without nuclease treatment (Table 1). Moreover, interaction 
sites for binding partners may overlap, and their competition for Matrin3 binding 
might be relevant for the different Matrin3 functions. Some of these interactions may 
require presence of Matrin3 within the nuclear matrix, which could serve as a 
scaffold for specific functions. The interaction between Matrin3 and LaminA26 is one 
such matrix associated interaction. Matrin3 binds to the tail of LaminA and 
immunofluorescence shows co-localization on the nuclear rim of differentiated 
C2C12 myotubules, although it is unclear if this is in the nuclear membrane or 
nuclear matrix. This interaction might be involved in the anchoring of the nuclear 
envelope bound lamins to the nuclear matrix, thereby ensuring structural integrity of 
the nucleus. 
 
Matrin3-related proteins 
Mammals possess two Matrin3-related proteins, RBM20 and ZNF638, which 
share its overall domain organization, including the related ZF and RRM domains 
(Fig. 1A). While Matrin3 and ZNF638 are widely expressed across different cell 
types, RBM20 expression is mostly restricted to the foetal and adult heart (Fig 1B). 
ZNF638 (originally known as NP220) has a pair of RRMs between the two C2H2 ZF 
domains31. Sequence identity is highest in the ZF and RRM domains, although 
RBM20 only has a single RRM domain. RBM20 shares 29% amino acid identity with 
Matrin3 over 43% of its length. Mapping of the RNA targets of RBM20 by CLIP 
revealed an optimal UCUU binding motif32, which is remarkably similar to the optimal 
binding sites for both Matrin3 (AUCUU)22, and PTBP1 (UUUCU/UCUU)22, 33. This is 
consistent with the fact that the first RRM of PTBP1 recognises YCU motif34 and has 
a high degree of identity with the RRMs of Matrin3 (40% and 35%) and RBM20 
(51%). RBM20 and ZNF638 lack the PRI motif found in Matrin3, and so presumably 
do not interact with the splicing regulator PTBP1. Nevertheless, both proteins were 
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found to regulate splicing35, 36, and have regions enriched in RS dipeptides, a feature 
commonly associated with splicing factors and regulators  
 
Matrin3 function in transcriptional regulation 
A number of functions have been suggested for Matrin3 throughout the life cycle of 
mRNAs, from the regulation of transcription, alternative splicing, viral RNA export, 
mRNA stability, to the DNA damage response. The role of Matrin3 in transcriptional 
regulation originates from the finding that Matrin3 interacts with the regions of DNA 
that are present within the scaffold/matrix attachment regions (S/MARs)3. These 
Matrin3-bound DNA regions augmented transcription when placed upstream of a 
promoter in a reporter plasmid37. Matrin3 binding decreased upon methylation of this 
DNA region, with a corresponding decrease in transcription, thereby suggesting that 
Matrin3 can activate transcription38. Matrin3 might not be the only factor involved in 
transcriptional activation by these DNA regions, given that these regions were 
isolated from the nuclear matrix scaffold that contain many proteins involved in 
transcription11, 37. Matrin3 was also found to bind to Pit1, a transcription factor 
involved in the activation of multiple genes, most notably the pituary hormone gene. 
Enhancer-bound Pit1 has to interact with the nuclear matrix to recruit the 
transcription factors beta-catenin and SATB1 to specific enhancer loci. The 
interaction of Pit1 with the nuclear matrix and Matrin3, requires beta-catenin and 
SATB1, and in absence of these factors Pit1 is unable to activate transcription. A 
disease-causing dominant negative mutation of Pit1 (R271W) disrupts the interaction 
with beta-catenin and SATB1, and consequent loss of association of enhancer 
occupied Pit-1 with the nuclear matrix. This interaction loss can be rescued by fusing 
Pit1 R271W to the nuclear matrix targeting region from hnRNPU/SAF-A, with the 
remarkable rescue of enhancer activation and recruitment of transcription co-
activators such as p300, and consequent transcription activation39. 
Transcription is thought to occur in a limited number of “transcription factories” 
at fixed locations in the nucleus40, which implies anchoring to a structural component 
that limits diffusion. Besides Matrin3, other components of the nuclear matrix impact 
transcription, positively and negatively. While Lamin B is associated with insulator 
sequences41, matrix-associated RNA-binding binding proteins seem to aid in 
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maintaining a transcriptional active environment. The nuclear matrix component 
hnRNPU is associated with sites of RNA pol II transcription42, and expression of a 
dominant negative mutant of hnRNPU destabilises the matrix in a similar manner as 
does RNase treatment43. Matrin3 has been found at RNA pol II initiation sites 
together with hnRNPU, highlighting the involvement of Matrin3 in a network of 
transcriptional activators44. 
 
Matrin3 function in splicing regulation 
Generation of alternative spliced mRNAs allows cells to expand their 
proteome45. Transcriptome-wide analysis of changes in alternative splicing upon 
Matrin3 depletion in HeLa cells revealed that Matrin3 regulates many alternative 
exons, mostly as a direct repressor but in some cases also as an activator19. While 
Matrin3 required its RRMs for splicing activation, no evidence of direct binding was 
found around the enhanced exons, suggesting that this function might be indirect. 
Matrin3 was identified as one of the main binding partners of the PTBP1 (Table 1), 
interacting with the second RRM domain of PTBP119. This interaction is mediated 
through a specific small linear motif GILGPPP found between Matrin3’s first ZF and 
the RRMs. This sequence conforms to a consensus PRI (PTBP1 RRM Interaction) 
motif, originally identified in the PTBP1 co-regulator Raver1 and shown to dock onto 
the dorsal surface of PTBP1 RRM246, 47, a domain important for PTBP1 repressor 
activity 48, 49. Despite this route of identification, comparison between splicing events 
regulated by Matrin3 or PTBP150 revealed that only a subset of events are co-
regulated by both proteins. This indicates that Matrin3 regulates most of its targets 
independently of PTBP1. Nevertheless, the activity of Matrin3 as a splicing regulator 
requires its PRI motif, for both PTBP1–dependent and –independent events 19 (and 
unpublished observations). This raises the hypothesis that Matrin3 might not only 
interact with PTBP1, but also with other co-regulatory proteins through its PRI motif, 
depending on the regulated splicing event. In fact, Matrin3 can interact with multiple 
RNA binding proteins (see Table 1) although it is not yet known which are involved in 
splicing co-regulation. 
The mechanism of splicing repression was examined by mapping Matrin3 
binding sites with nucleotide-resolution crosslinking immunoprecipitation (iCLIP). 
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Interestingly, Matrin3 interacts with broad sections of the pre-mRNA within the 
repressed exons and the flanking introns. In contrast to the splicing maps for many 
other splicing regulators25, Matrin3 binding was relatively uniform over a region 
encompassing 500 nucleotides flanking the repressed exons, with no specific peaks 
of binding. Matrin3 RNA-compete motifs were also enriched in the flanking introns, 
but not within the repressed exons19. This suggests a “bind and spread” model in 
which Matrin3 is recruited initially to the intronic high affinity binding sites, with 
subsequent recruitment of other Matrin3 molecules that interact and spread across 
the exon and flanking introns (Fig. 2). In support of this hypothesis, Matrin3 was 
found to interact with itself in a yeast two hybrid screen27. Another striking feature is 
that the introns flanking the Matrin3 repressed exons are significantly longer than 
those flanking other cassette exons, including those regulated by PTBP1. Longer 
introns may be required to prevent the “bind and spread” mode of action from 
affecting the flanking constitutive splice sites. 
 Notably, both of the Matrin3-related proteins RBM20 and ZNF638 have also 
been reported to regulate alternative splicing32, 35, 36, suggesting that it is a core 
function of this group of proteins. RBM20 has similar RNA binding preference to 
PTBP1 and Matrin3, consistent with the similarity between their RRMs (Fig 1). 
Strikingly, RBM20 appears to act primarily as a splicing repressor and like Matrin3 
binds within both introns flanking repressed exons 32. Despite these similarities, there 
are interesting contrasts. While Matrin3 interacts with a known splicing repressor 
PTBP1 via its PRI, RBM20 interacts with a number of core splicing factors, 
consistent with having an RS domain, as well as with hnRNPs32.  
 
Matrin3 function in RNA stability 
Steady-state RNA levels are determined by the rates of RNA synthesis and 
degradation. In addition to its roles in transcription, Matrin3 has also been implicated 
the stability of a number of mRNAs24. Since Matrin3 interacts with several 
transcription associated factors, such as DHX9 and hnRNPK, and the noncoding 
small RNA 7SK, the authors examined alterations in gene expression upon Matrin3 
depletion in U2OS cells. Matrin3 depletion decreases the mRNA levels of 77 genes, 
and Matrin3 binding to these mRNAs was indicated by RNA immunoprecipitation. 
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This interaction is dependent on the second RRM, which interestingly is also the one 
involved in the RNA-dependent interaction with DHX9 and hnRNPK. The reduced 
levels of these mRNAs were shown to be due to reduced RNA stability rather than 
transcriptional down-regulation, indicated by reduced mRNA half-life of three tested 
mRNAs24. The exact molecular mechanism of Matrin3-dependent mRNA 
stabilization is not entirely understood. However, a subset of stabilized mRNAs might 
be explained by nonsense mediated decay (NMD) linked to alternative splicing (AS-
NMD)19. These are splicing events in which one of the splicing patterns introduces a 
premature termination codon (PTC) leading to NMD51. Analysis of mRNA level and 
splicing changes upon Matrin3 knockdown showed that 15 out of 22 genes with 
changes in expression greater than 1.5 fold had an associated AS-NMD event that 
might explain the changes in mRNA level19. 
 
Matrin3 function in viral biology 
Viruses exploit their host systems to serve their own interests in several steps of 
their life cycle. Generation of infectious HIV-1 viral progeny requires the cytoplasmic 
export of several spliced and unspliced subgenomic HIV-1 mRNAs. The Rev protein 
is crucial in HIV-1 biogenesis and is produced by the fully spliced RNA, and in turn 
Rev facilitates the export of incompletely splic d RNAs that will express the other 
essential HIV-1 components, and ultimately genomic RNA for assembly of new HIV-
1 particles. Rev binds to the Rev Response Elements  (RRE) present in the RNA 
and together with host components it can escape the nucleus and lead the RNAs to 
the ribosome for expression of viral proteins (Reviewed in52). Two parallel studies 
using different approaches identified Matrin3 as a regulator of HIV-1 expression: one 
by RNA-affinity isolation of proteins interacting with the HIV-1 RNA and the other by 
yeast two hybrid screen using PTBP1 as a bait, as this splicing factor has been 
shown to affect HIV-1 gene expression53, 54. Manipulation of Matrin3 levels greatly 
affected the activity of Rev, indicative of a role of Matrin3 as a Rev co-regulator. Rev, 
Matrin3 and RRE-containing RNAs together form a complex suggesting that RNA 
bridges the Rev-Matrin3 interaction, and supporting this is the requirement for 
Matrin3’s RRMs for this activity. Here, as in some of the other Matrin3 associated 
functions, PSF also plays a role55. However their RNA association is only partially 
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overlapping. PSF is recruited to the RRE-containing RNA along with Rev co-
transcriptionally and is thought to be released before RNA accumulation at the 
nuclear matrix or its export, while Matrin3 is recruited post-transcriptionally and 
remains with the RNA in the nuclear matrix until its export.  Viral use of Matrin3 is 
possibly not restricted to HIV-1, and accordingly a kinase encoded by 
alphaherpesvirus ORF66 targets predominantly Matrin3, modifying threonine 150, 
which is required to avoid cytoplasmic aggregates of Matrin3 in later stages of 
infection similar to what has been observed with the lamins56, 57. 
Along with PSF and NONO, Matrin3 was also identified as a component of a 
complex involved in nuclear retention of RNA with long double-stranded regions, 
possibly associated with adenosine to inosine editing58. This could be of interest as a 
possible cellular antiviral mechanism. However, subsequent analyses suggest that 
this resulted from nuclear paraspeckle localization mediated by PSF and NONO, 
with no evidence for involvement of Matrin359. 
 
 
Matrin3 function in cell survival and DNA damage response 
The importance of the multiple functions of Matrin3 is evident from the 
dramatic effect of its depletion on cell proliferation and on the ability of cells to 
respond to DNA damaging compounds17, 60, 61. Matrin3 is involved in the response to 
several signals, such as the activation of NMDA receptors62 or the induction of DNA 
double strand breaks60. Both lead to post-translation modification of Matrin3 by 
phosphorylation at serine residues, with the former mediated by protein kinase 
A (PKA) and the latter by the kinase ataxia-telangiectasia mutated (ATM). PKA 
targets mainly a serine at position 18857 while ATM targets serine 20860. The 
consequences of these modifications are quite distinct. Matrin3 is the main PKA 
target upon NMDA receptor activation in rat brain, which culminates in Matrin3 
degradation and neuronal cell death, effects that can be blocked by PKA inhibitors62. 
Several caspases, typically activated/released during apoptosis, can cleave Matrin3, 
although it is not clear if this is the mechanism occurring during PKA-mediated 
degradation63. Down-regulation of Matrin3 by siRNA transfection in endothelial cells 
culminates in a decrease of cell proliferation followed by cell necrosis61. This 
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suggests that although Matrin3 down-regulation is involved in the regulated apoptotic 
death response to NMDA signalling, it is not sufficient and that in the absence of 
signalling Matrin3 depletion alone leads to necrotic cell death. The exact mechanism 
by which Matrin3 ensures proper cell proliferation is not clear, although it most likely 
will be related to its nuclear functions as it requires its nuclear localisation17. 
Persistent DNA damage can lead to cell death, and Matrin3 can function in 
several steps ensuring that only undamaged cells escape cell death, although no 
direct links between its role in DNA damage response and cell death have yet been 
reported. DNA double strand breaks (DDB) trigger ATM mediated phosphorylation of 
Matrin3 at serine 208, and this seems to be required for the DNA damage 
response60. This response involves activation of a cell cycle checkpoint that stalls 
cells to ensure sufficient time for DNA repair. Matrin3 can form a complex with 
proteins involved in DNA damage response, PSF and NONO, as well as the DNA 
binding proteins Ku80/Ku70, independent of any DNA damage. PSF and NONO are 
recruited to sites of DNA damage, and while Matrin3 itself is neither recruited nor 
affects the recruitment of other components, it does significantly alter the retention 
time of these proteins at the damage sites. This suggests that Matrin3 is involved in 
the early steps of the DNA damage response and is required for the dynamic 
recruitment and release of PSF/NONO from the damage site, although it is itself not 
recruited to the site60.  
 
Associations of Matrin3 with human diseases 
In addition to its effect on viruses such as HIV1, inherited mutations of Matrin3 
have also been shown to be associated with the neurodegenerative disease 
amyotrophic lateral sclerosis (ALS). ALS is a neurodegenerative disease affecting 
lower and upper motor neurons including the spinal cord, typically with adult onset. A 
Ser85Cys mutation in Matrin3 was found in 1998 as the autosomal dominant 
mutation in a family with multiple members diagnosed with myopathy64. 
Subsequently, a Phe115Cys mutation in Matrin3 was found to segregate with 
disease in a Sardinian family suffering from slow progressing ALS, and re-evaluation 
of the original family established that the Ser85Cys mutations also causes ALS65. 
Matrin3 mutations are rare in ALS, since in 96 patients with sporadic disease only 
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one missense mutation was found in Matrin3. Patients with Matrin3 Ser85Cys or 
Phe115Cys mutation suffer from brisk knee reflexes and a ‘split-hand’ pattern of 
weakness65, 66, symptoms also observed in other ALS patients. 
At the molecular level, Phe115Cys mutation leads to intra-nuclear inclusion, 
and a pronounced increase in Matrin3 protein abundance in the spinal cord neurons. 
Aggregation of Matrin3 is also seen in ALS patients with the more common C9orf72 
tri-nucleotide expansion, suggesting that aggregate formation of Matrin3 (and other 
RBPs) is widespread in ALS patients65. This phenotype is highly similar to other 
RBPs in which mutations lead to aggregation and manifestation of ALS or related 
motor neuron diseases, including TDP43, FUS, hnRNPA1 and hnRNPA267. The 
basis for pathology could be the loss of function of the protein(s), which may lead to 
deregulated alternative splicing. Alternatively, the aggregates may actively disrupt 
cellular functions via a toxic gain of function. The two mechanisms are not mutually 
exclusive and evidence has been presented for both in the cases of other RNA 
binding proteins such as TDP43 and FUS 68.  
As noted above, expression of the Matrin3-related protein RBM20 is restricted 
to the heart and is especially high in early development. Consistent with this, 
mutations of RBM20 were identified in 8 independent families associated with dilated 
cardiomyopathy69, 70. The missense mutations were all located in a hotspot 
corresponding to the arginine-serine domain of RBM20. Moreover, a large deletion of 
the RBM20 gene was found to be responsible for altered splicing of titin and other 
mRNAs in a rat model that also showed symptoms of dilated cardiomyopathy35. This 
suggests that the cardiomyopathy results from missplicing associated with loss of 
RBM20 function. It remains to be determined whether the mechanisms of ALS 
pathology arising from Matrin3 mutations are similar to the cardiomyopathy arising 
from RBM20 mutations. 
 
Conclusions and perspectives 
Evidence of the multiple functions of Matrin3 has accumulated over the last 25 years 
since it was discovered as a component of nuclear matrix. The full extent of 
functional coupling between the different stages of gene expression has also come 
into focus during this period, and like many other proteins, Matrin3 has clear roles at 
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numerous levels of gene expression. While it seems obvious that Matrin3 function is 
linked to the nuclear matrix, the extent to which its involvement in processes from 
transcriptional activation and pre-mRNA splicing to export of viral RNAs, requires 
anchoring of RNPs to the nuclear matrix remains unresolved. A precise mutation to 
specifically disrupt matrix localization would be an invaluable tool in this regard. 
Matrin3 function might in part be attributed to limiting diffusion of several co-factors, 
as suggested by the change in retention time of PSF and NONO upon DNA 
damage60. Much remains to be learned about the molecular interactions and cellular 
roles of Matrin3 and its related proteins, RBM20 and ZNF638, as well as the 
molecular basis of pathologies arising from their malfunction. The pace of 
discoveries about Matrin3 has accelerated over the past few years, with new insights 
emerging from several directions, including investigations of viral mechanisms and of 
diseases of motor neurons and the heart. We anticipate that Matrin3 will become a 
prime exemplar of the multiple ways in which RNP functions are inter-linked with 
genome organisation and the nuclear matrix. 
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Figure Legends 
Figure 1. Domain organization of Matrin3 and related proteins 
A) Schematic diagram of structural organization of Matrin3 (middle), ZNF638 (top) and 
RBM20 (bottom). The percent sequence identity between the RRM and ZF domains of 
Matrin3 compared to ZNF638 and RBM20 is indicated. Disease – associated aminoacid 
residues S85, F115, P154 and T622, and the phosphorylation sites at S188 and S208, are 
indicated. 
B) Relative expression of Matrin3, RBM20 and ZNF638 across human tissues. Darker red 
correlates with high expression levels and light red with low expression. Data taken from The 
Human Protein Atlas71. 
 
Figure 2. Proposed model for splicing regulation by Matrin3 
Cartoon depicting an exon not regulated by Matrin3 (A) and one regulated by Matrin3 (B). 
The presence of Matrin3 binding site (B – boxed sequence) on the introns flanking the exon 
recruits the Matrin3 molecules, which can be bound or not to other splicing regulators like 
PTBP1. 
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Table 1 – Matrin3 interacting proteins 
 
Protein 
Name 
Detection 
method 
Detected in 
Nuclear 
Matrix 
Uniprot 
Accession 
# 
Reference 
RNA 
processing 
CDC5L IP  Q99459 72 
CLK1 Y2H  P49759 27 
DDX17 IP  Q92841 24 
DDX39B Y2H  Q13838 27 
DDX5 
IPR,Y2H & 
GPD 
✔73 P17844 24, 27, 74 
HNRNPA1 IPR ✔75 P09651 76 
HNRNPA2/B1 IPR ✔75 P22626 76 
HNRNPC1/C2 IPR ✔75 P07910 76 
HNRNPL IP & Y2H ✔75 11 P14866 24, 27 
HNRNPK IP ✔75, 77 P61978 24 
HNRNPM IPR ✔11, 75 P52272 76 
HNRNPU IPR ✔11, 75 Q00839 76 
ILF2 IP  Q12905 24 
NONO IPR ✔78 Q15233 60 
NOVA1 Y2H  P51513 79 
NOVA2 Y2H  Q9UNW9 79 
PABPC1 IP ✔75 P11940 24 
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PCBP2 Y2H  Q15366 27 
PTBP1 IPR & GPD ✔75 78 P26599 19, 24 
PTBP2 Y2H  Q9UKA9 80 
PTBP3 IPR  O95758 81 
RBMX Y2H  P38159 27 
PSF IPR ✔78 P23246 60 55 
SFRS7 Y2H ✔11 Q16629 27 
SRPK2 Y2H  P78362 27 
TARDBP/TDP4
3 
IP  Q13148 
Freibaum et al, 
2010 
Transcription 
DDX3X IPR ✔11 O00571 76 
DHX9 IP ✔11 Q08211 24 
ERG IP & GPD  P11308  82 
FOXG1B Y2H  P55316 27 
NFX1 IP ✔11 Q12986 83 
NR2F1 Y2H  P10589 27 
RGS6 Y2H  P49758 27 
POU1F1/Pit1 IP ✔39 P28069 39 
POLR2A IP ✔6 P24928 84 
RPAP1 Y2H  Q9BWH6 27 
SAFB Y2H ✔85 Q15424 27 
SLTM Y2H ✔11 Q9NWH9 27 
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YBX1 Y2H  P67809 27 
ZHX1 Y2H  Q9UKY1 27 
Chromatin / 
Chromatin 
Remodeling 
BAZ1A Y2H  Q9NRL2 27 
CBX4 Y2H  O00257 27 
CHD3 Y2H  Q12873 27 
CTCF GPD  P49711 74 
H2AFX IP  P16104 86 
SIRT6 IP  Q8N6T7 87 
SMARCA4 Y2H ✔ 88 P51532 27 
SMARCAD1 IPR  Q9H4L7 89 
Translation 
RPL5 Y2H  P46777 27 
RPL18A Y2H ✔11 Q02543 27 
RPL10 Y2H  P27635 27 
RPS15A Y2H  P62244 27 
DNA 
replication / 
Repair 
GADD45GIP1 Y2H  Q8TAE8 27 
XRCC6 IP ✔ 90 P12956 60 
XRCC5 IP ✔ 90 P13010 60 
MCM7 IP & Y2H  P33993 27, 91 
TDG Y2H  Q13569 27 
Apoptosis 
DAXX Y2H  Q9UER7 27 
HIPK1 Y2H  Q86Z02 27 
BRE Y2H  Q9NXR7 27 
Signal 
Transduction 
PLCG1 Y2H  P19174 27 
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CIB1 Y2H  Q99828 27 
Nuclear 
Organization 
LMNA IPR & GPD ✔1, 11 P02545 26 
 
Y2H – Yeast two hybrid; IP – Immunoprecipitation; GPD – GST pulldown, 
R
 – Ribonuclease resistant 
interaction  
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Figure 1 - Matrin3 and related protein structure and expression  
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Figure 2 - Splicing Regulation by Matrin3  
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